I-PRF in traumatology
The use of I-PRF in traumatology promotes the regeneration of cartilage and connective tissue and the healing of defects. The most common indications are osteoarthritis and osteoarthritis, osteochondropathy, ligament damage, bursitis, tendinitis, lateral epicondylitis, chronic rotator cuff rupture. Medical research, as well as 7 years of experience in traumatology, has shown that I-PRF injections in these patients are effective in relieving pain, restoring damaged tissue and function, and ensuring a healing process and long-term results.
PRF - Platelet Rich Fibrin - derived from the patient's own blood.
Prior to the procedure, a small amount of blood (max. 26 ml) is taken from the patient in a sterile vacuum cleaner, which is centrifuged in a certain manner, resulting in fractional blood components.
The upper separated fraction containing activated platelets, leukocytes, fibrin and stem cells from the peripheral axis is used for injection. rites.
After injection, activated platelets and leukocytes, which are embedded in a 3-dimensional fibrin matrix, gradually begin to secrete growth factors for up to 28 days.
Increasing their concentration in cells promotes tissue bleeding, elastin, collagen, hyaluronic acid…. synthesis resulting in a sustained, long-term tissue regeneration process without adverse effects.
|32018||IPRF (autologās trombocītiem bagātinātās asins plazmas ievade)||100.00 €|
|32015||PRF i/artikulāra ievade||100.00 €|
|32019||PRF i/artikulāra ievade pensionāriem, 1.un 2.grupas invalīdiem, bērniem 3 līdz 18.g.v.||75.00 €|